← FDA Drug Approvals (Drugs@FDA)
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QUAGEN · Approved 2018-08-31
Drug application
- FDA Application #
ANDA210571- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
- Generic name
- Atropine Sulfate
- Active ingredients
- ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- QUAGEN
- First approval
- 2018-08-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown